Change of Director's Interest Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Healthscope Limited

ABN 64 144 840 639

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Paula Jane Dwyer

Date of last notice

16 December 2015

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Interest prior to change:

110,000 Ordinary Shares held indirectly by Happell Company Pty Ltd as trustee for the Happell Super Fund

Nature of indirect interest (including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

As detailed above

Date of change

9 May 2016

No. of securities held prior to change

As detailed above

Class

As detailed above

Number acquired

50,000 Ordinary Shares

Number disposed

Not applicable

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

$138,500 total trade value in respect of the purchase of Ordinary Shares

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

No. of securities held after change

110,000 Ordinary Shares held indirectly by Happell Company Pty Ltd as trustee for the Happell Super Fund

50,000 Ordinary Shares held indirectly by Roble Pty Limited as trustee for the Happell Family Trust

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

On-market purchase of 50,000 fully paid ordinary shares

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Not applicable

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed

above traded during a +closed period where prior written clearance was required?

No trading occurred during a closed period

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

Healthscope Limited published this content on 13 May 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 May 2016 23:48:05 UTC.

Original documenthttp://www.healthscope.com.au/download_file/view_inline/562

Public permalinkhttp://www.publicnow.com/view/76385BAB8A5ECF87ABD3CB4DBF526B7E3D79B5CF